US45780L1044 - Common Stock
INOGEN INC
NASDAQ:INGN (4/26/2024, 7:00:02 PM)
After market: 6.78 0 (0%)6.78
+0.3 (+4.63%)
Inogen, Inc. is a medical technology company, which engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company is headquartered in Goleta, California and currently employs 1,026 full-time employees. The company went IPO on 2014-02-14. The firm primarily develops, manufactures and markets portable oxygen concentrators (POCs) used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One systems concentrate the air around the patient to offer a single source of supplemental oxygen anytime, anywhere with a single battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. The Inogen One systems reduces the patients reliance on stationary concentrators and scheduled deliveries of tanks with a finite supply of oxygen. Inogen Connect is a wireless connectivity platform for the Inogen One G4, Inogen One G5 and Rove 6 consisting of a front-end mobile application for use by long-term oxygen therapy users and a back-end database portal for use by homecare providers. The firm also offers Simeox, a technology-enabled airway clearance and mucus management device.
INOGEN INC
859 Ward Drive
Goleta CALIFORNIA 93117
P: 18055620500
CEO: Nabil Shabshab
Employees: 1026
Website: https://www.inogen.com/
Shares of Inogen (INGN) were up 22% in afternoon trading Thursday after William Blair upgraded the stock to outperform, citing rival Phillips (PHG) Respironics’
Here you can normally see the latest stock twits on INGN, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: